基本信息
文件名称:Imeglimin-d3-EMD-387008-d-sub-3-sub-生命科学试剂-MCE.pdf
文件大小:464.14 KB
总页数:1 页
更新时间:2025-05-23
总字数:约2.99千字
文档摘要

Hotline:400-820-3792

Inhibitors?ScreeningLibraries?Proteins

www.MedChemE

Imeglimin-d3

Cat.No.:HY-14771S

Synonyms:EMD387008-d3

分?式:C?H??D?N?

分?量:157.23

作?靶点:Isotope-LabeledCompounds;MitochondrialMetabolism;

ReactiveOxygenSpecies

作?通路:Others;MetabolicEnzyme/Protease;

Immunology/Inflammation;NF-κB

储存?式:Pleasestoretheproductundertherecommendedconditionsin

theCertificateofAnalysis.

BIOLOGICALACTIVITY

?物活性Imeglimin-d3(EMD387008-d3)是氘代标记的Imeglimin.Imeglimin(EMD387008)是?种?服降糖剂。

Imeglimin可改善胰岛素敏感性。Imeglimin还减少活性氧(ROS)的产?,增加了线粒体DNA,并改善线粒体

功能[1]。

体外研究Stableheavyisotopesofhydrogen,carbon,andotherelementshavebeenincorporatedintodrugmolecules,

largelyastracersforquantitationduringthedrugdevelopmentprocess.Deuterationhasgainedattention

becauseofitspotentialtoaffectthepharmacokineticandmetabolicprofilesofdrugs.

REFERENCES

[1].RussakEM,etal.ImpactofDeuteriumSubstitutiononthePharmacokineticsofPharmaceuticals.AnnPharmaco